1994
DOI: 10.1111/j.1365-2249.1994.tb06607.x
|View full text |Cite
|
Sign up to set email alerts
|

Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity

Abstract: SUMMARYIn order to assess the ability of various serologic assays to correlate with lupus nephritis, we analysed sera obtained from 60 patients with systemic lupus erythematosus (SLE), Patients were categorized as having active nephritis (group 1), active lupus without nephritis (group 2), inactive lupus with prior nephritis (group 3), or inactive lupus without prior nephritis (group 4), Three parameters were assessed including anti-dsDNA antibodies (Farr assay), immune complexes (Clq binding), and anti-Clq an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

1996
1996
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…Affinity for glomerular antigens is a major determinant of the pathogenicity of anti‐dsDNA antibodies (18). Furthermore, there is excellent correlation between glomerular binding in vitro and renal disease in vivo (21, 22, 25). Accordingly, antibodies binding to both glomeruli and mesangial cells were defined as (potentially) pathogenic.…”
Section: Resultsmentioning
confidence: 99%
“…Affinity for glomerular antigens is a major determinant of the pathogenicity of anti‐dsDNA antibodies (18). Furthermore, there is excellent correlation between glomerular binding in vitro and renal disease in vivo (21, 22, 25). Accordingly, antibodies binding to both glomeruli and mesangial cells were defined as (potentially) pathogenic.…”
Section: Resultsmentioning
confidence: 99%
“…Several assay systems have been developed for detection of soluble complexes (Sobel et al, 1975;Hay et al, 1976;Digeon et al, 1977;, with different success rates. Previous studies have highlighted the importance of CIC in the pathogenesis of a variety of systemic disorders such as autoimmune diseases (Abrass et al, 1980;Nydegger and Davis, 1980;Bernstein et al, 1994), allergic diseases (Paganelli et al, 1981;Park and Nahm, 1998) and infectious diseases (Miles et al, 1993;Sengupta et al, 2002;Koraka et al, 2003). This suggests that CIC may be considered potential biomarkers of disease activity due to their diagnostic and prognostic value (Urbaniak-Kujda, 1996;Brunner and Sigal, 2001;Jaiswal et al, 2018;Thanadetsuntorn et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…After full text identification, 93 citations were excluded for the following reasons: mechanism studies, quantitative data without cut-off value, statistical analysis without relative risk or odds ratio (OR), SLE patients without renal involvement were not included as a control group or two by two fourfold table cannot be constructed. Ultimately, only 25 studies8,[10][11][12]16,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44] met the eligibility criteria of the meta-analysis, among them 22 studies8,10,12,16,[25][26][27][28][29][31][32][33][34][35][36][37][38][40][41][42][43] had sufficient data for the analysis in LN diagnosis and 9 studies10,…”
mentioning
confidence: 99%